Damora Therapeutics director files Form 4P
Damora Therapeutics reported a Form 4P filing for Director, President and CEO Jarrett JenniferP involving 12,500 shares at $20.23, or $252,875.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Damora Therapeutics reported a Form 4P filing for Director, President and CEO Jarrett JenniferP involving 12,500 shares at $20.23, or $252,875.